Theratechnologies Reports on its Annual Meeting of Shareholders
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.
Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:
|
FOR |
% FOR |
ABSTENTION |
% ABSTENTION | |||||
| Joseph Arena | 22,405,047 | 93.09 | % | 1,663,754 | 6.91 | % | ||
| Frank Holler | 21,008,601 | 87.29 | % | 3,060,200 | 12.71 | % | ||
| Paul Lévesque | 20,966,427 | 87.11 | % | 3,102,374 | 12.89 | % | ||
| Andrew Molson | 21,067,050 | 87.53 | % | 3,001,751 | 12.47 | % | ||
| Dawn Svoronos | 20,964,213 | 87.10 | % | 3,104,588 | 2.90 | % | ||
| Elina Tea | 21,734,254 | 90.30 | % | 2,334,547 | 9.70 | % | ||
| Dale Weil | 21,009,681 | 87.29 | % | 3,059,120 | 12.71 | % | ||
| Jordan Zwick | 23,107,383 | 96.01 | % | 961,418 | 3.99 | % | ||
Frank Holler will now act as Chair of the Board of Directors of the Company.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
